The number of people with susceptibility test result for rifampicin in Bahrain
Bahrain: The number of people with susceptibility test result for rifampicin was 112 in 2021. ▲ Rising
Latest (2021)
112
Change on year
up 36.6%
World rank
107th
of 155 countries
All-time high
112
in 2021
All-time low
79
in 2018
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Bahrain, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
In 2021, the number of people with susceptibility test result for rifampicin in Bahrain stood at 112. That is the highest value across all 5 years on record.
That represents a change of up 36.6% on the previous year and up 40.0% over five years.
That places Bahrain 107th out of 155 countries with data for 2021, putting it in the middle of the range.
The number of people with susceptibility test result for rifampicin in Bahrain, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 80 | — |
| 2018 | 79 | -1.2% |
| 2019 | 93 | +17.7% |
| 2020 | 82 | -11.8% |
| 2021 | 112 | +36.6% |
Bahrain compared with similar countries
- Bahrain's 112 is below the median for high income countries, which is 142, 79% of the median. (61 countries reporting)
- Bahrain's 112 is below the median for Middle East, North Africa, Afghanistan & Pakistan, which is 406, 28% of the median. (16 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 84 | 79 | 93 | 3 |
| 2020s | 97 | 82 | 112 | 2 |
Countries ranked near Bahrain
More health data for Bahrain
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.4635 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 476.9 deaths per 1,000 people (2090)
- Number of infants who die before age 1 41 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate 0.6427 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0292 units per person (2025)
- Population ages 00-04, male, annual growth rate 0.2418 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Bahrain?
- The number of people with susceptibility test result for rifampicin in Bahrain was 112 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Bahrain?
- The highest recorded value was 112 in 2021.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Bahrain?
- The lowest recorded value was 79 in 2018.
- How does Bahrain rank for the number of people with susceptibility test result for rifampicin?
- Bahrain ranks 107th out of 155 countries with data for 2021.
- Where does this Bahrain data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).